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Tissing et al. [7] reported a case of re- 
versible acute renal failure in a preterm in- 
fant under vancomycin treatment. They 
used however a dosage regimen which is 
no longer appropriate for preterm infants 
[6]. Several recently published controlled 
clinical studies demonstrated that a van- 
comycin dosage as low as 12 mg/kg per 
day does achieve therapeutic peak levels 
and trough levels above the irfinimal in- 
hibitory concentration [1-3]. 
In our own studies, 10 mg/kg per day 
used to prevent coagulase-negative staphy- 
lococcal septicaemia still led to vanco- 
mycin peak levels above 10 pg/1 (bacteri- 
cidal concentrations) and trough levels 
above the minimal inhibitory concentra- 
tion in 95% of 120 very low birth weight 
infants [4, 5]. The average creatinine lev- 
els were 62 ~mol/1 (+ 17 SD) on day 3 of 
treatment. Urine output and blood pressure 
did not change significantly. Creatinine 
levels on day 6 and after vancomycin 
treatment were not significantly different 
from levels on day 3. We believe a much 
lower dosage of vancomycin than that re- 
ported by Tissing et al. is adequate to pre- 
vent and treat coagulase-negative staphy- 
lococcal septicaemia. Vancomycin doses 
should be adjusted to post-conceptional 
age, birth-weight and pre-treatment creati- 
nine levels [5]. With that approach toxic 
symptoms are extremely unlikely. 
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Sir: Dr. M611er et al. comment that our 
regimen of vancomycin treatment (a daily 
dose of 30 mg/kg divided into two doses) 
[4] is not appropriate for preterm iiffants 
anymore. They furthermore suggest that 
several recently published clinical studies 
demonstrated that appropriate peak and 
trough levels of vancomycin are reached 
after a vancomycin dosage as low as 12 
mg/kg per day [1, 3]. We disagree with 
the comments of Mtl ler et al. Koren et al. 
[2, 3] recommend a daily regimen of 36 
mg/kg divided into two doses in patients 
with a postconceptional age between 31 
and 36 weeks and a body weight between 
1200 and 2000 g. We would like to em- 
phasise that our patient had a birth weight 
above 1500 g, a postconceptional age of 
33 weeks and a serum creatinine of 41 
gmol/1 (0.46 mg/dl). Kildoo et al. [2] rec- 
ommended that for patients over 2 weeks 
of age and with a postconcepfional age 
over 30 weeks, the serum creatinine 
should be used to determine the appropri- 
ate initial dosing regimen. A daily dose of 
30 mg/kg is recommended for patients 
with a serum creatinine < 53 gmol/1 (0.6 
mg/dl). Therefore, after using the serum 
creatinine and postconceptional age as our 
guide we therefore treated our patient ac- 
cordingly. 
We would like to stress that despite 
proper dosing based on postconceptional 
age and glomerular filtration rate, serum 
level monitoring is obligatory because of 
the wide interindividual variability and 
rapid changes in renal function. 
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